反応式
[CH:1]1([O:32][P:33]([O-:36])([O-:35])=[O:34])[CH:6]([O:7][P:8]([O-:11])([O-:10])=[O:9])[CH:5]([O:12][P:13]([O-:16])([O-:15])=[O:14])[CH:4]([O:17]P([O-])([O-])=O)[CH:3]([O:22]P([O-])([O-])=O)[CH:2]1[O:27]P([O-])([O-])=O.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+].[OH-].[Na+]>C(O)C>[C@H:4]1([OH:17])[CH:3]([OH:22])[C@@H:2]([OH:27])[C@@H:1]([O:32][P:33]([OH:36])([OH:35])=[O:34])[CH:6]([O:7][P:8]([OH:10])([OH:11])=[O:9])[C@@H:5]1[O:12][P:13]([OH:15])([OH:16])=[O:14]参加物
4
実験手順
100 ml of the fraction containing D-myo-inositol-1.2.6-triphosphate obtained in Example 15 was neutralized to a pH of about 7 with an aqueous solution of NaOH. After addition of 100 ml ethanol the volume of the solution was reduced by evaporation and the sodiumsalt was precipitated, centrifuged, recrystallized and dried in vacuum. The purified sodiumsalt of D-myo-inositol-1.2.6-triphosphate obtained was structurally confirmed by analysis with H-NMR.
後処理
- customwas reduced by evaporation
- customthe sodiumsalt was precipitated
- customrecrystallized
- customdried in vacuum
出典と根拠
- ORDレコード
- ord-bc91b0ea600744548cec0081e6df62c8
- 出典データセット
- uspto-grants-1989_07
- 特許番号
- US04851560
関連ノート
読み込み中…